Wellington Management Group’s Y-mAbs Therapeutics YMAB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-204,052
| Closed | -$904K | – | 2038 |
|
|
2025
Q1 | $904K | Buy |
204,052
+70,789
| +53% | +$314K | ﹤0.01% | 1721 |
|
|
2024
Q4 | $1.04M | Sell |
133,263
-3,451
| -3% | -$27K | ﹤0.01% | 1693 |
|
|
2024
Q3 | $1.8M | Sell |
136,714
-23,730
| -15% | -$312K | ﹤0.01% | 1555 |
|
|
2024
Q2 | $1.94M | Buy |
160,444
+14,141
| +10% | +$171K | ﹤0.01% | 1515 |
|
|
2024
Q1 | $2.38M | Buy |
+146,303
| New | +$2.38M | ﹤0.01% | 1485 |
|
|
2022
Q4 | – | Sell |
-1,948,469
| Closed | -$28.1M | – | 2134 |
|
|
2022
Q3 | $28.1M | Buy |
1,948,469
+78,090
| +4% | +$1.13M | 0.01% | 817 |
|
|
2022
Q2 | $28.3M | Sell |
1,870,379
-40,199
| -2% | -$608K | 0.01% | 849 |
|
|
2022
Q1 | $22.7M | Sell |
1,910,578
-2,360,804
| -55% | -$28M | ﹤0.01% | 985 |
|
|
2021
Q4 | $69.2M | Sell |
4,271,382
-6,715
| -0.2% | -$109K | 0.01% | 734 |
|
|
2021
Q3 | $122M | Sell |
4,278,097
-170,513
| -4% | -$4.87M | 0.02% | 569 |
|
|
2021
Q2 | $150M | Buy |
4,448,610
+1,428,152
| +47% | +$48.3M | 0.03% | 519 |
|
|
2021
Q1 | $91.3M | Buy |
3,020,458
+580,649
| +24% | +$17.6M | 0.02% | 637 |
|
|
2020
Q4 | $121M | Sell |
2,439,809
-215,243
| -8% | -$10.7M | 0.02% | 541 |
|
|
2020
Q3 | $102M | Buy |
2,655,052
+327,126
| +14% | +$12.6M | 0.02% | 513 |
|
|
2020
Q2 | $101M | Sell |
2,327,926
-416,379
| -15% | -$18M | 0.02% | 523 |
|
|
2020
Q1 | $71.6M | Buy |
2,744,305
+287,679
| +12% | +$7.51M | 0.02% | 535 |
|
|
2019
Q4 | $76.8M | Buy |
2,456,626
+2,046,011
| +498% | +$63.9M | 0.02% | 641 |
|
|
2019
Q3 | $10.7M | Buy |
+410,615
| New | +$10.7M | ﹤0.01% | 1144 |
|